Total Neoadjuvant Therapy With Short Course Radiation Therapy in Gastric Cancer

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

October 31, 2025

Primary Completion Date

April 30, 2030

Study Completion Date

April 30, 2030

Conditions
Gastric Cancer
Interventions
RADIATION

Short course radiation therapy

25 Gy in 5 fractions

DRUG

Standard of care neoadjuvant chemotherapy

Recommended options are CAPOX, FOLFOX, or FLOT but other standard of care chemotherapy may be given given at the discretion of the treating medical oncologist after consultation with the study Principal Investigator.

Trial Locations (4)

33612

Moffitt Cancer Center, Tampa

63110

Washington University School of Medicine, St Louis

90095

UCLA, Los Angeles

02215

Dana Farber Cancer Institute, Boston

All Listed Sponsors
lead

Washington University School of Medicine

OTHER